Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution

JCO Precis Oncol. 2019:3:PO.18.00138. doi: 10.1200/PO.18.00138. Epub 2019 Mar 27.
No abstract available

Keywords: BRAF V600E; CDKN2A; brain tumors; gliofibroma; pediatric; targeted therapy; trametinib; vemurafenib.